Literature DB >> 18309498

[Churg-Strauss syndrome].

J Zwerina1.   

Abstract

Churg-Strauss syndrome is a systemic ANCA-associated vasculitis arising almost exclusively in patients with a pre-existent asthma. Common clinical manifestations are marked blood eosinophilia, asthma, chronic sinusitis, cardiomyopathy, pulmonary infiltrates, gastrointestinal complaints and a multiplex neuropathy. The morphological substrate is an eosinophilic necrotizing vasculitis. Other eosinophilic disorders such as parasitic diseases, allergies and idiopathic hyper-eosinophilic syndrome have to be excluded. The mainstay of therapy is high-dose corticosteroids with the addition of cytotoxic drugs in patients with poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18309498     DOI: 10.1007/s00393-008-0284-7

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  22 in total

1.  Eosinophilia in Wegener's granulomatosis.

Authors:  M B Potter; R K Fincher; D R Finger
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

Review 2.  [Hypereosinophilic syndrome--recent developments in diagnosis and treatment].

Authors:  B Hellmich; K Holl-Ulrich; W L Gross
Journal:  Dtsch Med Wochenschr       Date:  2007-09       Impact factor: 0.628

3.  Rituximab in Churg-Strauss syndrome.

Authors:  M Koukoulaki; K G C Smith; D R W Jayne
Journal:  Ann Rheum Dis       Date:  2006-04       Impact factor: 19.103

4.  Churg-Strauss syndrome and pregnancy: successful treatment with intravenous immunoglobulin.

Authors:  Samara Amaris Rutberg; David E Ward; Bernard J Roth
Journal:  J Clin Rheumatol       Date:  2002-06       Impact factor: 3.517

5.  Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients.

Authors:  Anne Bourgarit; Philippe Le Toumelin; Christian Pagnoux; Pascal Cohen; Alfred Mahr; Véronique Le Guern; Luc Mouthon; Loïc Guillevin
Journal:  Medicine (Baltimore)       Date:  2005-09       Impact factor: 1.889

Review 6.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

7.  Interferon-alpha treatment of four patients with the Churg-Strauss syndrome.

Authors:  E Tatsis; A Schnabel; W L Gross
Journal:  Ann Intern Med       Date:  1998-09-01       Impact factor: 25.391

8.  A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.

Authors:  Jan Cools; Daniel J DeAngelo; Jason Gotlib; Elizabeth H Stover; Robert D Legare; Jorges Cortes; Jeffrey Kutok; Jennifer Clark; Ilene Galinsky; James D Griffin; Nicholas C P Cross; Ayalew Tefferi; James Malone; Rafeul Alam; Stanley L Schrier; Janet Schmid; Michal Rose; Peter Vandenberghe; Gregor Verhoef; Marc Boogaerts; Iwona Wlodarska; Hagop Kantarjian; Peter Marynen; Steven E Coutre; Richard Stone; D Gary Gilliland
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

Review 9.  Pulmonary involvement in unusual multisystem disorders.

Authors:  A Chanana; O P Sharma
Journal:  Curr Opin Pulm Med       Date:  1997-09       Impact factor: 3.155

10.  Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register.

Authors:  Eva Reinhold-Keller; Karen Herlyn; Rosemarie Wagner-Bastmeyer; Wolfgang L Gross
Journal:  Arthritis Rheum       Date:  2005-02-15
View more
  4 in total

1.  [Pulmonary allergic reactions].

Authors:  A R Koczulla; B Beutel; T Greulich; A Jerrentrup; C Vogelmeier
Journal:  Internist (Berl)       Date:  2012-08       Impact factor: 0.743

Review 2.  Diagnosis and therapeutic options for peripheral vasculitic neuropathy.

Authors:  Franz Blaes
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-04       Impact factor: 5.346

Review 3.  [Diagnosis and therapy of neurological manifestations of inflammatory rheumatic diseases].

Authors:  C Dejaco; T Seifert; C Duftner; M K Storch; F Fazekas; M Schirmer
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

Review 4.  [Ocular manifestations of Churg-Strauss syndrome: review article and case report].

Authors:  A Atili; C Richter; E Bahn; H H Rustenbeck; M Schittkowski
Journal:  Ophthalmologe       Date:  2013-11       Impact factor: 1.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.